Page last updated: 2024-09-04

edotreotide and Meningioma

edotreotide has been researched along with Meningioma in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's4 (30.77)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Beliveau, V; Dudas, J; Gizewski, ER; Heugenhauser, J; Iglseder, A; Iglseder, S; Kerschbaumer, J; Nevinny-Stickel, M; Nowosielski, M; Scherfler, C; Stockhammer, G; Uprimny, C; Virgolini, I1
Blau, T; Damman, P; Deuschl, C; Fendler, WP; Glas, M; Grueneisen, J; Guberina, M; Haubold, J; Kebir, S; Kessler, L; Li, Y; Milosevic, A; Morawitz, J; Schaarschmidt, BM; Styczen, H; Weber, M; Wrede, K1
Combs, SE; Debus, J; Dittmar, A; Dittmar, JO; Giesel, FL; Haberkorn, U; Habermehl, D; Kratochwil, C; Rieken, S; Welzel, T1
Bocci, V; Colandrea, M; Collamati, F; Cremonesi, M; Faccini, R; Ferrari, ME; Ferroli, P; Ghielmetti, F; Ghisini, R; Grana, CM; Mancini Terracciano, C; Marafini, M; Mirabelli, R; Morganti, S; Papi, S; Patanè, M; Pedroli, G; Pollo, B; Russomando, A; Schiariti, M; Solfaroli Camillocci, E; Traini, G1
Aricò, D; Baio, SM; Bartolomei, M; Bodei, L; Botteri, E; Cremonesi, M; De Cicco, C; Grana, CM; Paganelli, G; Sansovini, M1
Bamberg, M; Bares, R; Bartenstein, P; Belka, C; Eschmann, SM; Ganswindt, U; Gehler, B; Hauser, TK; Oksüz, MO; Paulsen, F; Pfannenberg, C1
Buck, AK; Flentje, M; Hänscheid, H; Kreissl, M; Löhr, M; Samnick, S; Sweeney, RA; Verburg, FA1
Beyer, T; Müller, AC; Pfannenberg, C; Thorwarth, D1
Bouterfa, H; Bushnell, D; Carlisle, T; Connolly, M; Kahn, D; Karwal, M; Madsen, M; Menda, Y; Miller, S; O'Dorisio, S; O'Dorisio, T; Ponto, J; Squires, S; Walkner, W1
Debus, J; Dimitrakopoulou-Strauss, A; Doll, J; Eisenhut, M; Haberkorn, U; Henze, M; Mäcke, HR; Milker-Zabel, S; Schuhmacher, J; Strauss, LG1
Debus, J; Haberkorn, U; Henze, M; Hoess, A; Huber, P; Milker-Zabel, S; Schulz-Ertner, D; Zabel-du Bois, A1
Becker, DW; Debus, J; Doll, J; Haberkorn, U; Henze, M; Hipp, P; Hofmann, M; Kowalski, J; Mäcke, HR; Schuhmacher, J1
Bohuslavizki, KH1

Trials

3 trial(s) available for edotreotide and Meningioma

ArticleYear
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Young Adult; Yttrium Radioisotopes

2009
Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
    Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:1

    Topics: Adult; Aged; Amino Acids; Arginine; Carcinoid Tumor; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Lysine; Male; Meningioma; Middle Aged; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Yttrium Radioisotopes

2004
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Brain; Female; Gallium Radioisotopes; Humans; Kinetics; Male; Meningeal Neoplasms; Meningioma; Metabolic Clearance Rate; Middle Aged; Octreotide; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals

2005

Other Studies

10 other study(ies) available for edotreotide and Meningioma

ArticleYear
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
    Journal of neuro-oncology, 2023, Volume: 164, Issue:3

    Topics: Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies

2023
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
    Nuclear medicine communications, 2023, Dec-01, Volume: 44, Issue:12

    Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography; Radiopharmaceuticals; Skull

2023
First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
    Radiation oncology (London, England), 2017, Nov-06, Volume: 12, Issue:1

    Topics: Adult; Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neuroimaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2017
The β
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2019, Volume: 58

    Topics: Beta Particles; Humans; Injections; Meningioma; Occupational Exposure; Octreotide; Positron-Emission Tomography; Radiation Dosage; Surgery, Computer-Assisted; Yttrium Radioisotopes

2019
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Radiation oncology (London, England), 2009, Nov-18, Volume: 4

    Topics: Adult; Aged; Aged, 80 and over; Female; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed

2009
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:8

    Topics: Adult; Aged; Biological Transport; Female; Gallium Radioisotopes; Humans; Male; Meningioma; Middle Aged; Molecular Targeted Therapy; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin

2012
Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2013, Volume: 194

    Topics: Aged; Female; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted

2013
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Adult; Aged; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Receptors, Somatostatin; Tomography, X-Ray Computed

2006
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:7

    Topics: Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Octreotide; Pilot Projects; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2001
Somatostatin receptor imaging: current status and future perspectives.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:7

    Topics: Gallium Radioisotopes; Humans; Indium Radioisotopes; Meningeal Neoplasms; Meningioma; Octreotide; Pentetic Acid; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

2001